Translational investigations in the HN1901 phase II window-of-opportunity study investigating the biological activity of an IDO1 (IO102) and PD-L1 (IO103) immune-modulatory peptide cancer vaccines in squamous cell carcinoma of the head and neck.
作者信息
Beyaert Simon, Loriot Axelle, Magremanne Michèle, Renwart William, Mahy Pierre, Duprez Thierry, Baldin Pamela, Benidovskaya Elena, Huyghe Nicolas, Dahou Hajar, Stroobant Vincent, Gomard Tiphanie, Machiels Jean-Pascal, Schmitz Sandra
机构信息
Institut de Recherche Expérimentale et Clinique (IREC), pôle MIRO, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Group of Computational Biology and Bioinformatics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
出版信息
Eur Arch Otorhinolaryngol. 2025 Sep 3. doi: 10.1007/s00405-025-09655-8.
PMID:40900323
Abstract
摘要
Zotero 插件